These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 21872448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA, Talpur R, Bassett RL, Duvic M.
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M, Miyagaki T, Ohmatsu H, Suga H, Kai H, Kamata M, Fujita H, Asano Y, Tada Y, Kadono T, Okochi H, Sato S.
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [Abstract] [Full Text] [Related]

  • 5. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
    Wasik MA, Vonderheid EC, Bigler RD, Marti R, Lessin SR, Polansky M, Kadin ME.
    Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
    [Abstract] [Full Text] [Related]

  • 6. Serum visfatin levels in patients with atopic dermatitis and cutaneous T-cell lymphoma.
    Suga H, Sugaya M, Miyagaki T, Kawaguchi M, Morimura S, Kai H, Kagami S, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.
    Eur J Dermatol; 2013 Jan; 23(5):629-35. PubMed ID: 24001451
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

  • 10. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL.
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [Abstract] [Full Text] [Related]

  • 11. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I, Estrach MT.
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [Abstract] [Full Text] [Related]

  • 12. On the diagnosis of erythrodermic cutaneous T-cell lymphoma.
    Vonderheid EC.
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():27-42. PubMed ID: 16412210
    [Abstract] [Full Text] [Related]

  • 13. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [Abstract] [Full Text] [Related]

  • 14. Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma.
    Suga H, Sugaya M, Miyagaki T, Ohmatsu H, Fujita H, Kagami S, Asano Y, Tada Y, Kadono T, Sato S.
    Acta Derm Venereol; 2013 Mar 27; 93(2):144-9. PubMed ID: 22948508
    [Abstract] [Full Text] [Related]

  • 15. Cutaneous T cell lymphoma complicating severe atopic dermatitis. Is making a diagnosis the main challenge?
    Meyer N, Mazereeuw-Hautier J, Launay F, Lamant L, Paul C.
    Dermatology; 2009 Mar 27; 218(2):168-71. PubMed ID: 19060456
    [Abstract] [Full Text] [Related]

  • 16. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC, Quéreux G, Brocard A, Ballanger F, Khammari A, Nguyen JM, Dréno B.
    Exp Dermatol; 2010 Aug 27; 19(8):e95-102. PubMed ID: 19845755
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M, Apisarnthanarax N, Cohen DS, Smith TL, Ha CS, Kurzrock R.
    J Am Acad Dermatol; 2003 Jul 27; 49(1):35-49. PubMed ID: 12833006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.